Yangzhou Zhonghui Pharmaceutical

Yangzhou Zhonghui Pharmaceutical is a Chinese pharmaceutical company based in Yangzhou, Jiangsu Province, specializing in the research, development, and large-scale manufacturing of finished drug products and active pharmaceutical ingredients (APIs). The company focuses primarily on chronic disease management, with a strong portfolio in cardiovascular health and metabolic disorders, including treatments for hypertension and type 2 diabetes. Their facilities are GMP-certified, supporting the production of oral solid dosage forms such as tablets and capsules for both domestic and international markets. Zhonghui Pharmaceutical is recognized for its production of high-quality generic medications, including widely used agents like metformin and amlodipine. The company operates within the Yangzhou Economic and Technological Development Zone, leveraging local infrastructure to maintain a competitive presence in the generic drug sector.